Abstract
AbstractMyotonic dystrophy type 2 (DM2) is caused by an expansion of CCTG repeats in the zinc‐finger protein gene (ZNF9). Transcribed CCUG repeats sequester muscleblind‐like protein 1 (MBNL1), an important alternative splicing regulator, preventing its normal function, leading to the disease phenotype. We describe a series of ligands that disrupt the MBNL1–r(CCUG)n interaction as potential lead agents for developing DM2 therapeutics. A previously reported triaminopyrimidine–acridine conjugate was a moderate inhibitor in vitro, however it proved to be poorly water‐soluble and not cell‐permeable. To improve its therapeutic potential, the new set of ligands maintained the key triaminopyrimidine recognition unit but replaced the acridine intercalator with a bisamidinium groove binder. The optimized ligands exhibit low micromolar inhibition potency to MBNL1–r(CCUG)8. Importantly, the ligands are the first to show the ability to disrupt the MBNL1–r(CCUG)n foci in DM2 model cell culture and exhibit low cytotoxicity.
References
32
Referenced
22
10.2353/ajpath.2010.100179
10.2174/138920210790886844
10.2353/ajpath.2009.090047
10.1523/JNEUROSCI.1983-09.2009
10.1111/j.1365-2990.2010.01068.x
10.1016/j.bbadis.2005.11.004
10.1093/hmg/ddl103
10.1016/j.jmb.2007.01.088
10.1021/ja804398y
10.1093/nar/gks298
10.1021/cb200408a
10.1002/cbic.200900716
10.1021/ja906877y
10.1089/hum.2012.212
10.1073/pnas.0903234106
10.1073/pnas.0901824106
10.1021/cb400046u
10.1021/jm400794z
10.1021/ja5012146
10.1021/cb900025w
10.1093/nar/gkr415
{'key': 'e_1_2_6_22_2', 'first-page': '7219', 'volume': '62', 'author': 'Lansiaux A.', 'year': '2002', 'journal-title': 'Cancer Res.'}
/ Cancer Res. by Lansiaux A. (2002)10.1128/JVI.72.6.4819-4824.1998
/ J. Virol. by Hung M. (1998)10.1021/cb200082d
10.1261/rna.610607
10.1021/cb4007387
10.1002/(SICI)1521-3765(19990104)5:1<381::AID-CHEM381>3.0.CO;2-T
10.1038/nprot.2006.179
10.1093/hmg/ddl181
10.1093/hmg/ddl137
10.1093/hmg/dds306
10.1093/nar/gkm601
Dates
Type | When |
---|---|
Created | 11 years, 2 months ago (June 17, 2014, 12:38 p.m.) |
Deposited | 1 year, 10 months ago (Oct. 11, 2023, 4:04 p.m.) |
Indexed | 2 weeks, 6 days ago (Aug. 3, 2025, 12:04 a.m.) |
Issued | 11 years, 2 months ago (June 17, 2014) |
Published | 11 years, 2 months ago (June 17, 2014) |
Published Online | 11 years, 2 months ago (June 17, 2014) |
Published Print | 10 years, 9 months ago (Nov. 1, 2014) |
@article{Nguyen_2014, title={Small Molecules that Target the Toxic RNA in Myotonic Dystrophy Type 2}, volume={9}, ISSN={1860-7187}, url={http://dx.doi.org/10.1002/cmdc.201402095}, DOI={10.1002/cmdc.201402095}, number={11}, journal={ChemMedChem}, publisher={Wiley}, author={Nguyen, Lien and Lee, JuYeon and Wong, Chun‐Ho and Zimmerman, Steven C.}, year={2014}, month=jun, pages={2455–2462} }